Decreased thrombin activity levels in PAR KO following 24 hours following ischemia. by Efrat Shavit-Stein (3186678)

“…<p>(A) Total thrombin activity is significantly decreased in PAR1 KO compared to WT mice (t-test). …”

Bay 61–3606 sensitizes MCF-7 cells to TRAIL by decreasing Mcl-1. by So-Young Kim (562174)

Gelsolin or cofilin overexpression rescues neurodegeneration and decreases inclusions in α-synuclein transgenic flies. by Souvarish Sarkar (8382513)

Genistein decreases mouse liver lnfection by <i>P. berghei</i> ANKA sporozoites. by Margarida Cunha-Rodrigues (65513)

MALT1 inhibition in mDCs decreases cytokine production in zymosan-treated cells. by Celine Dumont (9327751)

Decreased cytokine production by moDCs upon TLR stimulation when preincubated with NSAIDs. by Tonke K. Raaijmakers (13955749)

Analysis of mitochondrial morphology in Notch mutants and Notch signaling in Opa1 depleted type II NB lineages. by Dnyanesh Dubal (12085942)

Drp1^SD overexpression partially alleviates the differentiation defect seen in <i>notch</i> RNAi expressing type II NB lineages. by Dnyanesh Dubal (12085942)

Analysis of change in mature INPs, GMCs and neurons in the type II NB lineage on depletion of mitochondrial morphology proteins. by Dnyanesh Dubal (12085942)

KCl treatment increases Elk1 SUMOylation and decreases katanin-p60 expression. by Ece Selçuk (436963)

Drp1^SD overexpression in Opa1 or Marf depleted type II NBs rescues the reduced mitochondrial membrane potential. by Dnyanesh Dubal (12085942)

“…Scale bar- 10μm (A). Graph showing normalized TMRM intensities in +/+ (17 type II NBs, 8 brains), Drp1^SD (9,5), <i>opa1</i> RNAi (16,5), Drp1^SD;<i>opa1</i> RNAi 7,4), <i>marf</i> RNAi (11,5), Drp1^SD;<i>marf</i> RNAi (6,4) (B). …”

Opa1 and Marf depletion leads to fragmented mitochondria and overexpression of Drp1^SD leads to clustered mitochondria in type II NBs. by Dnyanesh Dubal (12085942)

Stimulation of α2-adrenergic receptors inhibits hippocampal precursor activity and decreases neurogenesis. by Dhanisha J. Jhaveri (577341)

“…<p>(A) Treatment of hippocampal precursor cells with α2-adrenergic receptor agonist at 10 uM significantly decreased neurosphere formation compared to the control. …”

Drp1^SD overexpression in <i>opa1</i> RNAi and <i>marf</i> RNAi expressing type II NB lineages suppresses the differentiation defect. by Dnyanesh Dubal (12085942)

Decreased sensitivity to apoptosis-related proteins in late passage <i>-/</i>- MEF cells. by Satoshi Miuma (117853)

Downregulation of Opa1 and Marf does affect type II NB numbers but affect differentiated cells in lineage. by Dnyanesh Dubal (12085942)

Excitation frequency decreases as fibroblasts density increases for all fibroblast island sizes (A - 2×2, B - 4×4, C - 6×6). by Ronit V. Oren (234285)

Knockdown of CoREST1 decreased tumor cell-mediated macrophage migration and activation. by Sohini Mazumdar (707540)

Expression of mRFP does not perturb the severity of <i>opa1</i> RNAi and <i>marf</i> RNAi phenotypes. by Dnyanesh Dubal (12085942)

UNC-62 RNAi decreases expression of collagen genes and increases expression of intestinal genes. by Eric L. Van Nostrand (30730)

“…(right) Worms were placed on either <i>unc-62</i> or control RNAi at day 1 of adulthood, and ∼30 worms for each were imaged and annotated at day 3 and day 6. Stacked bars indicate the percent of worms that were observed as class A (light grey), class B (dark grey), or class C (black).…”